Please login to the form below

Not currently logged in
Email:
Password:

Trump Blueprint

This page shows the latest Trump Blueprint news and features for those working in and with pharma, biotech and healthcare.

Fireworks likely at Senate drug pricing hearing today

Fireworks likely at Senate drug pricing hearing today

The hearing comes against the backdrop of a recent probe into insulin pricing introduced by Grassley and his Democrat counterpart on the committee, Ron Wyden, as well as President Trump’s ... Trump’s blueprint contains some fairly unpalatable

Latest news

  • End to middlemen rebates a major shift in US drug pricing End to middlemen rebates a major shift in US drug pricing

    Puts onus on pharma, which cites rebates as biggest barrier. The Trump administration plans to ban rebates paid by pharma to insurance middlemen, and instead wants to see them passed directly ... The changes fulfil promises made by President Trump last

  • FDA takes aim at pharma’s biosimilar-delaying tactics FDA takes aim at pharma’s biosimilar-delaying tactics

    The obstructive practices were referred to as ‘gaming’ in President Trump’s blueprint document which was unveiled earlier this year, as part of a package of measures that are aimed at ... Reference pricing is one of the measures being considered in

  • Reference price bill tabled in US House and Senate Reference price bill tabled in US House and Senate

    Reference pricing is one of the proposals that has been put forward by Trump since he published a blueprint to reduce medicine prices earlier this year. ... due to high deductibles and co-insurance”, which is another of Trump’s proposals.

  • Pfizer CEO reckons rebates will disappear, and that’s a positive Pfizer CEO reckons rebates will disappear, and that’s a positive

    Speaking on the company’s second-quarter results call, he said that eliminating rebates – one of the main themes of President Donald Trump’s blueprint for reducing drug pricing – would be ... Read’s comments came shortly after Pfizer’s much

  • Trump attempts The Art of the Deal with pharma Trump attempts The Art of the Deal with pharma

    The President of the United States recently unveiled his long-awaited plan to lower prescription drug prices in America.Trump’s plan, called American Patients First, The Trump Administration Blueprint to ... Trump wants the rest of the world to pony up

More from news
Approximately 2 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
huumun formerly PharmiWeb Solutions

huumun, is a digital transformation business. For us, digital transformation means using digital technologies, not just to turn an existing...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics